Entrada Therapeutics Inc (TRDA)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
6 TIDE STREET BOSTON, MA 02210

Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets that have long been considered inaccessible and undruggable.

View SEC Filings from TRDA instead.

View recent insider trading info

Funds Holding TRDA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TRDA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

13.7 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOSHI DIPAL PRESIDENT AND CEO

  • Officer
  • Director
208,710 2022-07-27 6

WENTWORTH KORY JAMES CHIEF FINANCIAL OFFICER

  • Officer
33,019 2022-07-01 3

KREHER NERISSA CHIEF MEDICAL OFFICER

  • Officer
31,032 2022-07-01 4

DOWDEN NATHAN J CHIEF OPERATING OFFICER

  • Officer
33,788 2022-07-01 4

SETHURAMAN NATARAJAN CHIEF SCIENTIFIC OFFICER

  • Officer
34,763 2022-07-01 3

BAKER BROS. ADVISORS LP

BAKER JULIAN

BAKER FELIX

BAKER BROS. ADVISORS (GP) LLC

  • 10% Owner
4,865,819 2022-06-02 4

KIM PETER S

  • Director
11,918 2022-06-02 2

THISTLE MARY

  • Director
11,918 2022-06-02 2

CROWLEY JOHN F

  • Director
11,918 2022-06-02 3

FOLEY TODD

  • Director
  • 10% Owner
11,918 2022-06-02 3

PARMAR KUSH

  • Director
  • 10% Owner
11,918 2022-06-02 4

NUECHTERLEIN CAROLE

  • Director
11,918 2022-06-02 2

ROCHE HOLDING LTD

ROCHE FINANCE LTD

  • 10% Owner
2,813,525 2021-11-02 1

MPM BIOVENTURES 2014, L.P.

EVNIN LUKE

GADICKE ANSBERT

MPM BIOVENTURES 2014 (B), L.P.

MPM ASSET MANAGEMENT INVESTORS BV2014 LLC

MPM BIOVENTURES 2014 LLC

MPM BIOVENTURES 2014 GP LLC

MPM BIOVENTURES 2018 (B), L.P.

MPM ASSET MANAGEMENT INVESTORS BV2018 LLC

  • 10% Owner
12,568,328 2021-11-02 1

5AM VENTURES V, L.P.

5AM PARTNERS V, LLC

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
5,290,736 2021-11-02 1

REDMILE GROUP, LLC

GREEN JEREMY

REDMILE BIOPHARMA INVESTMENTS III, L.P.

  • 10% Owner
1,954,420 2021-11-02 1

MPM BIOVENTURES 2018, L.P.

MPM BIOVENTURES 2018 LLC

MPM BIOVENTURES 2018 GP LLC

  • 10% Owner
12,568,328 2021-11-02 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DOSHI DIPAL - Director - Officer PRESIDENT AND CEO

2022-07-29 16:03:33 -0400 2022-07-27 S 2,000 $12.00 d 208,710 direct yes 2.9361 -7.0812 2.9361 2 -7.0812 6

DOWDEN NATHAN J - Officer CHIEF OPERATING OFFICER

2022-07-06 16:18:17 -0400 2022-07-01 A 33,788 a 33,788 direct

SETHURAMAN NATARAJAN - Officer CHIEF SCIENTIFIC OFFICER

2022-07-06 16:16:10 -0400 2022-07-01 A 34,763 a 34,763 direct

DOSHI DIPAL - Director - Officer PRESIDENT AND CEO

2022-07-06 16:15:35 -0400 2022-07-01 A 90,750 a 90,750 direct

WENTWORTH KORY JAMES - Officer CHIEF FINANCIAL OFFICER

2022-07-06 16:20:09 -0400 2022-07-01 A 33,019 a 33,019 direct

KREHER NERISSA - Officer CHIEF MEDICAL OFFICER

2022-07-06 16:19:07 -0400 2022-07-01 A 31,032 a 31,032 direct

DOWDEN NATHAN J - Officer CHIEF OPERATING OFFICER

2022-06-29 16:02:52 -0400 2022-06-27 S 7,714 $13.00 d 64,893 direct yes -1.4778 -3.3662 3.6946 5.0903 21 -20.7718 12

DOSHI DIPAL - Director - Officer PRESIDENT AND CEO

2022-06-29 16:02:05 -0400 2022-06-27 S 4,000 $12.00 d 210,710 direct yes -1.4778 -3.3662 3.6946 5.0903 21 -20.7718 12

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 22:15:03 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 21:45:04 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 21:15:04 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 20:45:04 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 20:15:05 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 19:45:03 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 19:15:05 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 18:45:03 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 18:15:04 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 17:45:04 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 17:15:05 UTC -50.2885 52.6085 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 16:45:04 UTC -50.4607 52.7807 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 16:15:04 UTC -50.4607 52.7807 10000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 15:45:04 UTC -50.4607 52.7807 3000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 15:15:05 UTC -50.4607 52.7807 3000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 14:45:04 UTC -50.4607 52.7807 2000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 14:15:05 UTC -50.4607 52.7807 4000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 13:45:04 UTC -50.4607 52.7807 4000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 13:15:04 UTC -50.4607 52.7807 3000
ENTRADA THERAPEUTICS INC TRDA 2022-08-12 12:45:04 UTC -50.4607 52.7807 3000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TRDA -1200.0 shares, $-11268.0 2022-03-31 N-PORT

Elevate your investments